SCHEMBL135941

SCHEMBL135941

O=C1CN=C(c2ccccc2)O1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.42
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
KMT2A Q03164 4/20 0.38
MAPT P10636 4/20 0.38
GAA P10253 3/20 0.38
MEN1 O00255 2/20 0.38
USP1 O94782 1/20 0.36
WDR48 Q8TAF3 1/20 0.36
CFTR P13569 1/20 0.35
GOPC Q9HD26 1/20 0.35
GABRA1 P14867 1/20 0.35
GABRG2 P18507 1/20 0.35
GABRB3 P28472 1/20 0.35
GABRA5 P31644 1/20 0.35
GABRA3 P34903 1/20 0.35
GABRA2 P47869 1/20 0.35
GABRB2 P47870 1/20 0.35
ALDH1A1 P00352 4/20 0.35
HPGD P15428 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6135895 0.89 NPC1 (0.33) SMN1; SMN2NPC1RAB9A
SCHEMBL6699746 0.86 NPC1 (0.35) SMN1; SMN2NPC1RAB9AKMT2AMAPT
SCHEMBL11126769 0.81 ALOX15 (0.42) SMN1; SMN2NPC1RAB9AKMT2AMAPT
Gamma-Aminobutyric Acid SCHEMBL5795191 0.81 HDAC3 (0.41) SMN1; SMN2KMT2AMAPTMEN1GABRA1
SCHEMBL10448205 0.80 NPC1 (0.45) SMN1; SMN2NPC1RAB9AKMT2AGAA
SCHEMBL17512909 0.80 USP1 (0.37) SMN1; SMN2NPC1RAB9AGAAUSP1
SCHEMBL8915564 0.80 NOTUM (0.44) SMN1; SMN2NPC1RAB9AKMT2AMAPT
SCHEMBL6699184 0.79 ALOX15 (0.41) SMN1; SMN2NPC1RAB9AKMT2AMAPT
SCHEMBL16516875 0.78 KMT2A (0.43) SMN1; SMN2NPC1RAB9AKMT2AMAPT
SCHEMBL5855957 0.78 GSTP1 (0.46) SMN1; SMN2KMT2AMAPTMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 937 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116120252-B Preparation method of ramipril key intermediate derivative 浙江工业大学 2024-10-29 CN claimed
CN-116120252-A Preparation method of ramipril key intermediate derivative 浙江工业大学 2023-05-16 CN claimed
CN-109320554-B Novel method for synthesizing practical acetaminoacrylate compound 浙江海翔药业股份有限公司 2021-04-27 CN claimed
US-20160102065-A1 NOVEL COMPOUND HAVING SKIN-WHITENING, ANTI-OXIDIZING AND PPAR ACTIVITIES AND MEDICAL USE THEREOF PUSAN NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION (KR) 2016-04-14 US claimed
US-6461810-B1 DIAGNOSING GENETIC DISORDERS; GENETIC ENGINEERING PRINCETON UNIVERSITY 2002-10-08 US claimed
WO-2002004020-A2 PATHOGEN RESISTANCE IN ORGANISMS MPB COLOGNE GMBH (DE) 2002-01-17 WO claimed
US-5911987-A NEWCASTLE DISEASE VIRUS DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OFFENTLICHEN RECHTS (DE) 1999-06-15 US claimed
WO-1999024622-A1 TRIPLEX IN-SITU HYBRIDIZATION PRINCETON UNIVERSITY (US) 1999-05-20 WO claimed
EP-0832286-A4 MODIFIED NUCLEOTIDES FOR NUCLEIC ACID LABELING ONCOR INC (US) 1998-11-04 EP claimed
EP-0832286-A1 MODIFIED NUCLEOTIDES FOR NUCLEIC ACID LABELING ONCOR, INC. (US) 1998-04-01 EP claimed
EP-0223177-B1 CARDIOTONIC PHENYL OXAZOLONES MERRELL DOW PHARMACEUTICALS INC. (US) 1992-08-19 EP claimed
EP-0282669-B1 HERBICIDAL 1,5-DIPHENYL-1H-1, 2,4-TRIAZOLE-3-CARBOXAMIDE DERIVATIVES KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) 1992-07-01 EP claimed
EP-0282303-B1 1,5-DIPHENYL-1H-1,2,4-TRIAZOLE-3-CARBOXAMIDE DERIVATIVES AND HERBICIDAL COMPOSITION CONTAINING THE SAME KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) 1992-01-15 EP claimed
EP-0367233-A2 Process for the preparation of 2-(2-thienyl)-ethylamine and derivatives thereof OCCIDENTAL CHEMICAL CORPORATION (US) 1990-05-09 EP claimed
US-4874876-A ACYLATING THIOPHENE, REDUCING, HYDROLYZING OCCIDENTAL CHEMICAL CORPORATION (US) 1989-10-17 US claimed
EP-0310555-A1 Derivatives of 1,5-diphenyl-1,2,4-triazole-3-carboxylic acid for crop protection against the phytotoxic activity of herbicides CIBA-GEIGY AG (CH) 1989-04-05 EP claimed
EP-0297734-A2 A derivative of 1,5-diphenyl-1H-1,2,4-triazole-3-carboxamide, herbicidal compositions containing the derivative and process for producing the derivative KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) 1989-01-04 EP claimed
EP-0282669-A1 Herbicidal 1,5-diphenyl-1H-1, 2,4-triazole-3-carboxamide derivatives KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) 1988-09-21 EP claimed
EP-0282303-A1 1,5-Diphenyl-1H-1,2,4-triazole-3-carboxamide derivatives and herbicidal composition containing the same KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) 1988-09-14 EP claimed
EP-0220956-A2 Herbicidal 1,2,4-triazole-3-carboxamides KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) 1987-05-06 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160102065-A1 NOVEL COMPOUND HAVING SKIN-WHITENING, ANTI-OXIDIZING AND PPAR ACTIVITIES AND MEDICAL USE THEREOF PPARG, PPARA, TYR SMN1; SMN2 3671/4885NPC1 3522/4885RAB9A 3882/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.